Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs Indian Medical PG Practice Questions and MCQs

Question 511: Which of the following is NOT an effect of atropine?

A. Rise of body temperature
B. Decreased salivary secretion
C. Bradycardia (Correct Answer)
D. Increased A-V conduction

Explanation: **Explanation:** Atropine is a classic **competitive muscarinic antagonist**. To understand its effects, remember that it blocks the "Rest and Digest" parasympathetic system, leading to "Sympathetic-like" outcomes. **Why Bradycardia is the correct answer:** Atropine typically causes **tachycardia** (increased heart rate) by blocking $M_2$ receptors on the SA node, thereby removing the vagal "brake" on the heart. While very low doses of atropine can cause transient initial bradycardia (due to blockade of presynaptic inhibitory $M_1$ receptors on vagal nerve endings), its **primary, definitive clinical effect is tachycardia**. Therefore, bradycardia is not considered a standard effect of atropine. **Analysis of other options:** * **A. Rise of body temperature:** Atropine inhibits sweat glands ($M_3$ blockade). In children, this can lead to "Atropine fever" because the body cannot dissipate heat through evaporation. * **B. Decreased salivary secretion:** Atropine is a potent antisialogogue. It blocks $M_3$ receptors on salivary glands, leading to a dry mouth (xerostomia). * **C. Increased A-V conduction:** By blocking vagal influence at the Atrioventricular (AV) node, atropine shortens the refractory period and increases conduction velocity. This is why it is used in certain types of heart block. **High-Yield NEET-PG Pearls:** 1. **Drug of Choice:** Atropine is the DOC for **symptomatic sinus bradycardia** and **Organophosphate poisoning**. 2. **Mnemonic for Atropine Toxicity:** "Hot as a hare (fever), Red as a beet (flushing), Dry as a bone (no sweat/saliva), Blind as a bat (cycloplegia/mydriasis), and Mad as a hatter (delirium)." 3. **Contraindication:** Strictly avoided in patients with **Angle-closure Glaucoma** (due to mydriasis causing increased intraocular pressure) and **Benign Prostatic Hyperplasia** (due to risk of urinary retention).

Question 512: In the beginning of resuscitation efforts, 0.5 mg of epinephrine is administered subcutaneously. Which adrenergic receptors, in which tissues, are responsible for the beneficial effect of epinephrine in this patient?

A. Alpha-1 receptors in vascular smooth muscle, alpha-2 receptors in the heart, and beta-1 receptors in bronchial smooth muscle
B. Alpha-1 receptors in vascular smooth muscle, alpha-2 receptors at presynaptic nerve terminals, beta-1 receptors in bronchial smooth muscle
C. Alpha-1 receptors in vascular smooth muscle, beta-1 receptors in the heart, and beta-2 receptors in bronchial smooth muscle (Correct Answer)
D. Alpha-2 receptors in vascular smooth muscle and beta-2 receptors in vascular smooth muscle

Explanation: ### Explanation Epinephrine (Adrenaline) is a potent agonist of all alpha and beta-adrenergic receptors. In resuscitation (such as anaphylaxis or cardiac arrest), its therapeutic benefits are derived from its multi-receptor action: 1. **Alpha-1 receptors (Vascular Smooth Muscle):** Activation causes **vasoconstriction**, which increases peripheral vascular resistance and blood pressure, helping to reverse hypotension and reduce mucosal edema. 2. **Beta-1 receptors (Heart):** Activation leads to **positive inotropic** (increased contractility) and **chronotropic** (increased heart rate) effects, improving cardiac output. 3. **Beta-2 receptors (Bronchial Smooth Muscle):** Activation causes **bronchodilation**, which is critical for relieving bronchospasm and improving oxygenation. #### Analysis of Incorrect Options: * **Option A:** Incorrect because **Alpha-2** receptors are not the primary mediators of cardiac stimulation; Beta-1 is responsible. Also, **Beta-1** receptors are not found in bronchial smooth muscle (Beta-2 is the dominant receptor there). * **Option B:** Incorrect because **Alpha-2** (presynaptic) activation generally inhibits neurotransmitter release and does not provide a primary beneficial effect in acute resuscitation. **Beta-1** is incorrectly linked to bronchial muscle. * **Option D:** Incorrect because it ignores the vital **Beta-1** cardiac effects and the primary **Alpha-1** vasoconstrictive mechanism required for resuscitation. #### NEET-PG High-Yield Pearls: * **Drug of Choice (DOC):** Epinephrine is the DOC for **Anaphylactic Shock** (Route: IM, 1:1000 concentration) and **Cardiac Arrest** (Route: IV/IO, 1:10,000 concentration). * **Biphasic Response:** At low doses, Beta-2 effects (vasodilation) may predominate; at high doses, Alpha-1 effects (vasoconstriction) take over. * **Metabolism:** Epinephrine is metabolized by **MAO** and **COMT**; its primary urinary metabolite is **VMA (Vanillylmandelic acid)**.

Question 513: What is the effect of vagal stimulation on the heart?

A. Increased heart rate
B. Increased RR interval in ECG (Correct Answer)
C. Increased cardiac output
D. Increased force of contraction

Explanation: **Explanation:** The vagus nerve provides **parasympathetic** innervation to the heart, primarily via the release of **Acetylcholine (ACh)**. ACh acts on **M2 muscarinic receptors** located predominantly in the SA and AV nodes. 1. **Why Option B is Correct:** Vagal stimulation causes **negative chronotropy** (decreased heart rate). It achieves this by hyperpolarizing the nodal cells and slowing the rate of phase 4 spontaneous depolarization. On an ECG, a decrease in heart rate directly manifests as an **increase in the RR interval** (the time between two successive R waves). 2. **Why Incorrect Options are Wrong:** * **Option A:** Increased heart rate (positive chronotropy) is a result of **Sympathetic** stimulation (Beta-1 receptors), not vagal. * **Option C:** Cardiac output (CO = Stroke Volume × Heart Rate) **decreases** with vagal stimulation because the heart rate drops significantly. * **Option D:** Increased force of contraction (positive inotropy) is a sympathetic effect. Vagal fibers have minimal innervation of the ventricles; thus, their effect on ventricular contractility is negligible compared to their effect on rate. **High-Yield Clinical Pearls for NEET-PG:** * **Vagal Maneuvers:** Carotid sinus massage or the Valsalva maneuver increases vagal tone and is used clinically to terminate **Supraventricular Tachycardia (SVT)** by slowing AV node conduction. * **Atropine:** A muscarinic antagonist used to treat symptomatic bradycardia because it blocks vagal influence ("vagolytic"). * **Reflex Bradycardia:** Drugs that cause sudden vasoconstriction (like Phenylephrine) trigger a baroreceptor reflex, leading to increased vagal tone and a compensatory increase in the RR interval.

Question 514: Which glaucoma drug is a beta-1 selective beta-blocker?

A. Timolol
B. Levobunolol
C. Carteolol
D. Betaxolol (Correct Answer)

Explanation: Betaxolol is a **cardioselective (Beta-1 selective)** adrenergic antagonist [2]. In the management of glaucoma, it works by blocking $\beta_1$ receptors on the ciliary epithelium, thereby reducing the production of aqueous humor and lowering intraocular pressure (IOP) [1]. Because it is $\beta_1$ selective, it carries a lower risk of inducing bronchospasm compared to non-selective agents, making it the preferred beta-blocker for patients with co-existing respiratory conditions like asthma or COPD (though it should still be used with caution) [1]. **2. Analysis of Incorrect Options:** * **Timolol (A):** The "Gold Standard" for glaucoma treatment, but it is a **non-selective** beta-blocker ($\beta_1 + \beta_2$). It is contraindicated in patients with asthma/COPD due to the risk of life-threatening bronchospasm from $\beta_2$ blockade. * **Levobunolol (B):** A potent **non-selective** beta-blocker similar to Timolol, often used for its long duration of action. * **Carteolol (C):** A **non-selective** beta-blocker that possesses **Intrinsic Sympathomimetic Activity (ISA)**. It is unique because it may cause less bradycardia and has a "membrane-stabilizing" effect, but it is not $\beta_1$ selective. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** Remember **"B"** for **B**etaxolol is **B**eta-1 selective. * **Efficacy:** While safer for the lungs, Betaxolol is slightly **less effective** at lowering IOP compared to Timolol. * **Side Effects:** Local side effects of topical beta-blockers include stinging, burning, and dry eyes. Systemic absorption can lead to bradycardia and heart block. * **Contraindications:** All topical beta-blockers are generally contraindicated in patients with 2nd or 3rd-degree heart block or severe bradycardia.

Question 515: What is the recommended treatment for atropine toxicity?

A. 2-Pralidoxime
B. Naloxone
C. Flumazenil
D. Physostigmine (Correct Answer)

Explanation: **Explanation:** **Correct Answer: D. Physostigmine** **Mechanism of Action:** Atropine toxicity is characterized by competitive antagonism of muscarinic receptors (causing symptoms like "mad as a hatter, dry as a bone, red as a beet"). **Physostigmine** is the drug of choice because it is a **tertiary amine** acetylcholinesterase inhibitor. Unlike other carbamates (like Neostigmine), Physostigmine is lipid-soluble and **crosses the blood-brain barrier (BBB)**. This allows it to reverse both the peripheral and the life-threatening central anticholinergic effects (delirium, seizures, coma) of atropine. **Analysis of Incorrect Options:** * **A. 2-Pralidoxime (2-PAM):** This is a cholinesterase reactivator used specifically for **Organophosphate poisoning**. It would worsen atropine toxicity as atropine is actually used as an antidote for OP poisoning. * **B. Naloxone:** A competitive opioid antagonist used to reverse **Opioid overdose** (respiratory depression/miosis). * **C. Flumazenil:** A competitive GABA-A receptor antagonist used to reverse **Benzodiazepine overdose**. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Atropine Toxicity:** "Hot as a hare (hyperthermia), Red as a beet (flushing), Dry as a bone (anhidrosis), Blind as a bat (mydriasis/cycloplegia), Mad as a hatter (delirium)." * **Why not Neostigmine?** Neostigmine is a quaternary ammonium compound; it does not cross the BBB and therefore cannot treat the central CNS symptoms of atropine toxicity. * **Contraindication:** Physostigmine should be avoided in Tricyclic Antidepressant (TCA) overdose as it may aggravate cardiac conduction defects.

Question 516: Latanoprost is used for which of the following conditions?

A. Maintenance of ductus arteriosus
B. Pulmonary hypertension
C. Gastric mucosal protection
D. Glaucoma (Correct Answer)

Explanation: **Explanation:** **Latanoprost** is a synthetic analog of **Prostaglandin F2̱ (PGF2̱)** [1]. It is the first-line treatment for **Open-Angle Glaucoma** and ocular hypertension [1],[2]. **Why Option D is Correct:** Latanoprost acts as a selective agonist at **FP receptors** [2]. Its primary mechanism of action in the eye is increasing the **uveoscleral outflow** of aqueous humor (rather than affecting the trabecular meshwork) [1]. By facilitating the drainage of fluid through the ciliary muscle into the suprachoroidal space, it effectively lowers intraocular pressure (IOP) [1]. **Why Other Options are Incorrect:** * **A. Maintenance of ductus arteriosus:** This is achieved using **Alprostadil (PGE1)** [1]. Conversely, NSAIDs like Indomethacin are used to close a patent ductus arteriosus. * **B. Pulmonary hypertension:** While prostaglandins are used here, the specific drugs are **Epoprostenol (PGI2)** or its analogs like Treprostinil and Iloprost [1]. * **C. Gastric mucosal protection:** This is the clinical use of **Misoprostol (PGE1 analog)**, which increases bicarbonate/mucus secretion and inhibits gastric acid [1]. **Clinical Pearls for NEET-PG:** 1. **Side Effects:** A high-yield side effect of Latanoprost is **increased brown pigmentation of the iris** and **hypertrichosis** (thickening and darkening of eyelashes). 2. **Dosing:** It is preferred because of its once-daily dosing schedule, which improves patient compliance. 3. **Other Analogs:** Bimatoprost and Travoprost share the same mechanism. Bimatoprost is also FDA-approved for treating eyelash hypotrichosis.

Question 517: Edrophonium binds to which site of Acetylcholinesterase?

A. Anionic site (Correct Answer)
B. Esteric site
C. Both the sites
D. Doesn't bind to any site

Explanation: **Explanation:** The enzyme Acetylcholinesterase (AChE) has two primary binding domains: the **Anionic site** (containing glutamate) and the **Esteric site** (containing a serine residue) [1]. **Why Option A is Correct:** Edrophonium is a quaternary ammonium compound. It binds **only to the Anionic site** of the enzyme through reversible ionic/electrostatic interactions [1]. Because it does not form a covalent bond with the esteric site, its action is extremely short-lived (5–15 minutes) [1], [2]. **Analysis of Incorrect Options:** * **Option B (Esteric site):** This site is responsible for the actual hydrolysis of Acetylcholine. Organophosphates bind irreversibly to this site (phosphorylation) [2]. * **Option C (Both sites):** Carbamates (like Neostigmine and Physostigmine) bind to both the anionic and esteric sites [1]. They carbamylate the esteric site, leading to a longer duration of action compared to Edrophonium. * **Option D:** Incorrect, as Edrophonium is a competitive inhibitor that must bind to the enzyme to prevent the breakdown of Acetylcholine. **NEET-PG High-Yield Pearls:** 1. **Tensilon Test:** Edrophonium was historically used for the diagnosis of Myasthenia Gravis (MG) due to its rapid onset and short duration [2]. A positive test shows transient improvement in muscle strength. 2. **Differentiation:** It is used to differentiate a **Myasthenic crisis** (improvement with Edrophonium) from a **Cholinergic crisis** (worsening with Edrophonium) [2]. 3. **Structure:** Being a quaternary ammonium, it is polar and **does not cross the Blood-Brain Barrier (BBB)** [1]. 4. **Antidote:** Atropine should always be kept ready during a Tensilon test to manage potential bradycardia or excessive salivation.

Question 518: Which of the following drugs should be avoided in a patient with adrenaline-producing pheochromocytoma?

A. Phentolamine (Correct Answer)
B. Enalapril
C. Clonidine
D. Methyldopa

Explanation: **Explanation:** The correct answer is **Phentolamine**. This question tests the understanding of the **"Adrenaline Reversal" (Dale’s Vasomotor Reversal)** phenomenon. **Why Phentolamine is avoided (in specific contexts):** In a patient with an adrenaline-producing pheochromocytoma, the circulating adrenaline acts on both **$\alpha$-receptors** (vasoconstriction) and **$\beta_2$-receptors** (vasodilation). Normally, the $\alpha$-effect predominates, maintaining high blood pressure. If a non-selective $\alpha$-blocker like **Phentolamine** is administered, it blocks the $\alpha$-mediated vasoconstriction. This leaves the $\beta_2$-mediated vasodilation unopposed, leading to a precipitous and dangerous drop in blood pressure (hypotension). While Phentolamine is used in the *management* of pheochromocytoma, it must be used with extreme caution or avoided if the patient is unstable, as it can trigger severe tachycardia and unpredictable BP swings. *(Note: In clinical practice, Phentolamine is actually used to control hypertensive crises in pheochromocytoma; however, in the context of NEET-PG "avoidance" questions, it refers to the risk of "Adrenaline Reversal" or the danger of using $\beta$-blockers before $\alpha$-blockers).* **Why other options are incorrect:** * **Enalapril (ACE Inhibitor):** Does not interact with the adrenergic receptor balance and is safe to use for general hypertension. * **Clonidine & Methyldopa ($\alpha_2$ Agonists):** These are centrally acting sympatholytics. Clonidine is actually used in the "Clonidine Suppression Test" to diagnose pheochromocytoma (it fails to lower catecholamines in these patients). **NEET-PG High-Yield Pearls:** 1. **Rule of Pheochromocytoma:** Always give **$\alpha$-blockers BEFORE $\beta$-blockers**. Giving a $\beta$-blocker first leads to unopposed $\alpha$-stimulation, causing a hypertensive crisis. 2. **Drug of Choice:** **Phenoxybenzamine** (irreversible $\alpha$-blocker) is the DOC for pre-operative management. 3. **Adrenaline Reversal:** Conversion of the pressor response of adrenaline to a depressor response by $\alpha$-blockers.

Question 519: Which one of the following is a relatively selective 02 adrenergic blocker with a short duration of action?

A. Prazosin
B. Yohimbine (Correct Answer)
C. Terazosin
D. Doxazosin

Explanation: **Explanation:** The question asks for a selective **$\alpha_2$ adrenergic blocker** with a short duration of action. **Why Yohimbine is Correct:** Yohimbine is an alkaloid derived from the bark of the *Pausinystalia johimbe* tree. It acts as a **competitive, selective $\alpha_2$ receptor antagonist**. By blocking presynaptic $\alpha_2$ receptors, it increases the release of norepinephrine into the synaptic cleft, leading to increased sympathetic outflow. It has a relatively **short half-life (approx. 30–40 minutes)**, necessitating frequent dosing if used clinically. While historically used for erectile dysfunction, its clinical utility is now limited due to side effects like tachycardia and hypertension. **Why the Other Options are Incorrect:** * **Prazosin:** This is a highly selective **$\alpha_1$ blocker**. It is used in the treatment of hypertension and Benign Prostatic Hyperplasia (BPH). It is famous for the "first-dose phenomenon" (postural hypotension). * **Terazosin & Doxazosin:** These are also selective **$\alpha_1$ blockers** similar to Prazosin but have a much **longer duration of action** (Doxazosin has a half-life of ~22 hours), allowing for once-daily dosing. They are primarily used for BPH. **High-Yield NEET-PG Pearls:** * **$\alpha_2$ Agonists vs. Antagonists:** Remember that $\alpha_2$ agonists (Clonidine, Methyldopa) *decrease* sympathetic outflow, while $\alpha_2$ antagonists (Yohimbine, Idazoxan) *increase* it. * **Mirtazapine:** Another clinically important drug with $\alpha_2$ blocking properties, used as an atypical antidepressant. * **Reversal of Toxicity:** Yohimbine can theoretically be used to reverse the toxicity of $\alpha_2$ agonists like Xylazine (common in veterinary medicine). * **Selectivity Rule:** Drugs ending in **"-zosin"** are generally selective $\alpha_1$ blockers.

Question 520: Which antihistaminic agent possesses a high anticholinergic profile?

A. Astemizole
B. Diphenhydramine (Correct Answer)
C. Terfenadine
D. Fexofenadine

Explanation: **Explanation:** The correct answer is **Diphenhydramine**. **1. Why Diphenhydramine is correct:** Antihistamines are classified into first and second generations. **Diphenhydramine** is a **first-generation H1-receptor antagonist**. These agents are highly lipophilic (crossing the blood-brain barrier) and lack selectivity for the H1 receptor. They significantly antagonize **muscarinic receptors**, leading to a high anticholinergic profile. This results in classic side effects such as dry mouth, blurred vision, urinary retention, and constipation. **2. Why the other options are incorrect:** * **Astemizole & Terfenadine (Options A & C):** These are second-generation antihistamines. They were designed to be more selective for peripheral H1 receptors and have minimal to no anticholinergic activity. *Note: Both have been largely withdrawn from the market due to the risk of QT prolongation and Torsades de Pointes.* * **Fexofenadine (Option D):** This is a third-generation (or advanced second-generation) antihistamine and is the active metabolite of terfenadine. It is highly selective for peripheral H1 receptors, does not cross the blood-brain barrier, and is virtually devoid of anticholinergic effects. **3. NEET-PG High-Yield Pearls:** * **First-generation H1 blockers** (e.g., Diphenhydramine, Promethazine, Hydroxyzine) are used clinically for their sedative and anticholinergic properties (e.g., in motion sickness or Parkinsonism). * **Anticholinergic Toxidrome mnemonic:** "Blind as a bat, mad as a hatter, red as a beet, hot as a hare, dry as a bone." * **Fexofenadine** is the "least sedating" antihistamine because it is a substrate for the P-glycoprotein efflux pump in the blood-brain barrier. * **Drug Interaction:** Terfenadine and Astemizole toxicity increases when co-administered with CYP3A4 inhibitors (e.g., Ketoconazole, Erythromycin).

Practice by Chapter

Cholinergic Agonists

Practice Questions

Cholinergic Antagonists

Practice Questions

Adrenergic Agonists

Practice Questions

Adrenergic Antagonists

Practice Questions

Ganglionic Agents

Practice Questions

Neuromuscular Blocking Agents

Practice Questions

Autonomic Drugs in Ophthalmology

Practice Questions

Autonomic Drugs in Cardiovascular Disease

Practice Questions

Autonomic Drugs in Respiratory Disease

Practice Questions

Autonomic Drugs in Urological Disorders

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free